These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23926446)

  • 1. Synthesis and Biological Activity of
    Markowska A; Bruzgo M; Gorodkiewicz E; Surażyński A
    Int J Pept Res Ther; 2013; 19(3):191-198. PubMed ID: 23926446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and activity of N-sulfonylamides of tripeptides as potential urokinase inhibitors.
    Markowska A; Bruzgo I; Miltyk W; Midura-Nowaczek K
    Protein Pept Lett; 2010 Oct; 17(10):1300-4. PubMed ID: 20594155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripeptides with non-code amino acids as potential serine proteases inhibitors.
    Markowska A; Bruzgo M; Surażyński A; Midura-Nowaczek K
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and activity of amides of tripeptides as potential urokinase inhibitors.
    Markowska A; Bruzgo I; Midura-Nowaczek K
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):139-42. PubMed ID: 20030517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.
    Callas D; Bacher P; Iqbal O; Hoppensteadt D; Fareed J
    Thromb Res; 1994 May; 74(3):193-205. PubMed ID: 8042188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors.
    Purwin M; Markowska A; Bruzgo I; Rusak T; Surażyński A; Jaworowska U; Midura-Nowaczek K
    Int J Pept Res Ther; 2017; 23(2):235-245. PubMed ID: 28491013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of catalytic activities of serine proteases by tripeptides compounds.
    Hiwasa T; Ogawa S; Kobayashi H; Ike Y
    FEBS Lett; 1996 May; 386(1):47-50. PubMed ID: 8635601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of alkylamides of dipeptides as potential plasmin inhibitors.
    Midura-Nowaczek K; Lepietuszko I; Bruzgo I
    Acta Pol Pharm; 2006; 63(1):33-7. PubMed ID: 17515327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.
    Morita T; Kato H; Iwanaga S; Takada K; Kimura T
    J Biochem; 1977 Nov; 82(5):1495-8. PubMed ID: 591514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and kinetic evaluation of peptide alpha-keto-beta-aldehyde-based inhibitors of trypsin-like serine proteases.
    Lynas JF; Martin SL; Walker B
    J Pharm Pharmacol; 2001 Apr; 53(4):473-80. PubMed ID: 11341363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.
    Kettner C; Shaw E
    Biochemistry; 1978 Oct; 17(22):4778-84. PubMed ID: 728386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibitors of the serine protease plasmin: probing the S3 and S3' subsites using a combinatorial library.
    Xue F; Seto CT
    J Med Chem; 2005 Nov; 48(22):6908-17. PubMed ID: 16250649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
    Hijikata A; Okamoto S; Kikumoto R; Tamao Y
    Thromb Haemost; 1979 Oct; 42(3):1039-45. PubMed ID: 159513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
    Odake S; Kam CM; Powers JC
    J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of a Novel Series of KTTKS Analogues on Cytotoxicity and Proteolytic Activity.
    Tałałaj U; Uścinowicz P; Bruzgo I; Surażyński A; Zaręba I; Markowska A
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31618846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombin.
    Deadman JJ; Elgendy S; Goodwin CA; Green D; Baban JA; Patel G; Skordalakes E; Chino N; Claeson G; Kakkar VV
    J Med Chem; 1995 Apr; 38(9):1511-22. PubMed ID: 7739010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of ketomethylene pseudopeptide analogues as thrombin inhibitors.
    Cheng L; Goodwin CA; Schully MF; Kakkar VV; Claeson G
    J Med Chem; 1992 Sep; 35(18):3364-9. PubMed ID: 1527787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.